The establishment of astrocytes-melanoma cells interactions in which MCP-1, overexpressed by astrocytes, enhanced in vitro melanoma tumorigenic properties (proliferation, migration, and invasion) drove us to further evaluate the effect of inhibiting MCP-1 via bindarit. Here, CCL2 is linked to melanoma.